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ReviewSomatic Hypermutation of
Immunoglobulin Genes: Merging
Mechanisms for Genetic Diversity
these higher affinity antibodies proliferate and survive
preferentially. Successive cycles of mutation and selec-
tion lead to the generation of B cells with very high-
affinity antibodies, a phenomenon that Siskind and Ben-
acerraf (1969) termed “affinity maturation.”
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specificities is a consequence of a high rate of mutationYale School of Medicine
confined to a few genes in antibody-producing cells and310 Cedar Street
to postulate that the increase in affinity might be theNew Haven, Connecticut 06510
result of selection of clones by antigens. A theory to
explain how such mutation might be achieved was origi-
nally put forward by Brenner and Milstein (1966), whoSomatic hypermutation is critical for the generation
proposed a model in which an unknown targeting mech-of high-affinity antibodies and effective immune re-
anism directed a specific nuclease to the antibodysponses, but its molecular mechanism remains poorly
genes. After DNA cleavage, error-prone repair wouldunderstood. Recent studies have identified DNA
resolve the lesion into a mutation. Weigert, Cohn, andstrand lesions associated with the hypermutation pro-
colleagues first observed hypermutation at work bycess and suggested the involvement of specific repair
studying variability in mouse  light chains at the proteinmolecules and pathways. Particularly exciting has
level. In their landmark paper (Weigert et al., 1970), theybeen the discovery of a putative RNA editing enzyme,
inferred some basic features of the process: the mutantthe activation-induced cytidine deaminase (AID), that
 chains were all derived from one germline sequence;is required for all immunoglobulin gene-specific modi-
variability was not randomly distributed, but insteadfication reactions (somatic hypermutation, class switch
amino acid changes tended to cluster in “specificity”recombination, and gene conversion). Parallels be-
regions; and replacements in such regions were sequen-tween these three reactions are considered in light of
tially selected for by antigen. Hypermutation was laterrecent advances.
confirmed at the DNA level (Bernard et al., 1978) and
was causally linked to affinity maturation soon thereafterIn his landmark monograph “The Specificity of Serologi-
(Griffiths et al., 1984). Finally, advances in transgeniccal Reactions,” Landsteiner (1936) documented how the
technology, coupled with the realization that light chainimmune system could produce antibodies to almost any
transgenes can ectopically hypermutate in vivo (O’Brienforeign substance. This amazing ability to generate di-
et al., 1987), ushered in a period of extensive studiesversity is one of the hallmarks of acquired immunity. At
into the molecular mechanism of SHM.the same time, immune reactions are specific for the
The prescient model of Brenner and Milstein still pro-particular antigen. The observation of an increase in the
vides the rough outline of our current understanding ofspecificity of serum to a substance over time was not
SHM. Mechanistically, we divide the reaction into atrigorously tested until Siskind and Eisen (1965) clearly
least three phases: targeting, DNA recognition anddemonstrated that, after injecting small amounts of anti-
cleavage, and repair. Transcription is thought to play a
gen in rabbits, there was a gradual increase in the intrin-
key role in targeting of a nuclease to the Ig locus (Jacobs
sic affinity of serum antibodies to the antigen.
and Bross, 2001). It is not clear what is being recognized
We now understand that immunoglobulin (Ig) and T by the nuclease, although there is some sequence speci-
cell receptor genes are generated by the somatic recom- ficity to the process (Michael et al., 2002). The cleavage
bination of a relatively small number of gene segments step is thought to result in the production of a DNA
in a process known as V(D)J recombination (Tonegawa, double strand break (DSB) (Bross et al., 2000; Papavasi-
1983). In many species, including primates and rodents, liou and Schatz, 2000), although a single strand lesion
this assembly reaction generates much or all of the pre- might precede the DSB (Kong and Maizels, 2001). Fi-
immune diversity in these antigen receptors, with combi- nally, the DSB is probably repaired into a mutation
natorial diversity alone enough to generate up to 107 through the action of a subset of error-prone polymer-
different antibody specificities. Ig molecules from the ases (Gearhart and Wood, 2001).
preimmune repertoire, however, generally bind antigens While V(D)J recombination is used by all jawed verte-
with only modest affinity and specificity, and fine tuning brates to assemble antigen receptor genes, diversity in
of the antibody response is driven by another lympho- the preimmune antibody repertoire can be generated
cyte-specific process known as somatic hypermutation by other means: SHM (in sheep), gene conversion (in
(SHM). This reaction is triggered when the Ig on the pigs, cows, chickens), or by a combination of both reac-
surface of B cells engages antigen and involves the tions (in rabbits) (Diaz and Flajnik, 1998). Maizels (1995)
introduction of point mutations into the variable regions was the first to propose that, despite their obvious differ-
of Ig genes. Some of the mutagenized antibodies will ences (Figure 1), SHM and gene conversion are varia-
have a higher affinity for the antigen, and cells harboring tions on a common mechanism, an idea strongly sup-
ported by recent findings (Sale et al., 2001). Perhaps
more surprising still are the emerging links between3 Correspondence: david.schatz@yale.edu
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Figure 1. AID-Dependent Mechanisms that Diversify Ig Genes
(A) Schematic diagram of the Ig heavy chain locus, with the variable (VDJ) and constant (C) region exons represented as blue and gray
rectangles, respectively, switch regions as ovals, and promoter (P), enhancer (E), and 3 regulatory regions (3RR) regions as black circles.
Not to scale.
(B) Somatic hypermutation causes point mutations (x) in the vicinity of the V exon. Thin arrows represent transcription in (B), (C), and (D).
(C) Gene conversion involves the transfer of sequence information from a pseudogene (V) into the variable region exon.
(D) Class switch recombination involves looping out and deletion of DNA between two switch regions (in this case, between S and S),
thereby swapping the constant region of the expressed heavy chain.
SHM, gene conversion, and class switch recombination targeting, hypermutability of the locus is vastly dimin-
ished (Fukita et al., 1998), and if the promoter is dupli-(CSR) (Honjo et al., 2002), most dramatically illustrated
by the discovery of the activation-induced cytidine de- cated upstream of the constant region, then that region
begins to hypermutate (Peters and Storb, 1996). The linkaminase (AID), whose function is essential for all three
reactions (Arakawa et al., 2002; Harris et al., 2002; Mura- between mutation and transcription is very tight, with
the frequency of mutation directly correlated to the ratematsu et al., 2000; Revy et al., 2000). CSR alters the
constant region and hence effector functions (but not of transcription (Bachl et al., 2001; Goyenechea et al.,
1997).the antigen specificity) of antibodies through a looping
out and deletion process (Figure 1). With the discovery These data might argue for a specific role of the Ig V
gene promoter in targeting, but additional experimentsof AID and gathering evidence of mechanistic overlap
between SHM, CSR, and gene conversion, these fields have shown that this is not the case. The variable region
promoter can be replaced with heterologous promotersappear poised for major advances.
(Betz et al., 1994; Tumas-Brundage and Manser, 1997),
and hypermutation is not unduly compromised as longThe Targeting Phase of SHM
as the heterologous promoters are transcriptionally ac-Transgenic experiments from several laboratories have
tive. It is not yet clear whether these findings translateshown that mutations occur in the variable region exon
into a general requirement for a pol II promoter orand the surrounding 1 to 2 kb (Winter and Gearhart,
whether the need for a promoter is more generic; re-1998). The variable region promoter forms an upstream
placement of the V region promoter with pol I (Fukita etboundary to hypermutation (Lebecque and Gearhart,
al., 1998) or pol III (Shen et al., 2001) promoters yielded1990), and mutations peak over the rearranged variable
inconclusive results. In these experiments, hypermuta-region. However, when the V gene is replaced with artifi-
tion was not compromised, but the pol I and pol IIIcial substrates (bacterial sequences, the human -glo-
promoters generated pol II-type transcripts (capped andbin gene, etc.), those substrates hypermutate success-
polyadenylated). Thus it is not clear whether hypermuta-fully, and so the sequence of the V gene itself does not
tion can utilize a non-pol II promoter or whether in theseplay a role in targeting the mutation process (Yelamos
experiments the transgenic promoters were simply hi-et al., 1995). A particularly important observation is that
jacked by cryptic pol II elements.the probability of mutation declines with increasing dis-
Since neither the Ig V region nor its promoter is essen-tance from the promoter, with the decline being reason-
tial for hypermutation, what accounts for the specificably well fit by an exponential (Rada and Milstein, 2001).
targeting of the process to Ig genes? Ig enhancer ele-As a result, the frequency of mutation is highest in the
ments appear to provide at least part of the answer. Theupstream portion of the V exon (encoding complemen-
well-defined Ig intronic and 3 enhancers are individu-tarity determining region 1) and declines thereafter, with
ally necessary (Betz et al., 1994) but together not suffi-mutations rarely if ever found in the downstream con-
stant region exons. If the promoter is removed by gene cient (Klix et al., 1998) to target hypermutation to trans-
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genic substrates, and it appears that other, poorly
defined sequences in the vicinity of the enhancers play
an important role (Klix et al., 1998; Winter et al., 1998).
The 3  enhancer is sufficient to support hypermutation
of a 1 transgene (Kong et al., 1998), but the Ig heavy
chain intronic enhancer does not drive efficient hyper-
mutation of Ig heavy chain transgenes, despite the fact
that the transgenes are heavily transcribed (reviewed in
Storb et al., 1998b). It remains unclear what sequences
are responsible for the targeting of hypermutation, espe-
cially for the Ig heavy chain locus. What is clear is that
the targeting function of enhancers and other cis-acting
sequences can be uncoupled from their role in driving
transcription. For example, in a construct containing a
strong, enhancer-independent promoter, transcription
was constitutive but mutation was absolutely dependent
on the presence of the Ig enhancers (Papavasiliou and
Schatz, 2000). It is unclear whether “mutational en-
hancers” are position dependent (unlike conventional
transcriptional enhancers) (Bachl et al., 1998; Winter et
al., 1998) or position independent (Klix et al., 1998; Papa-
vasiliou and Schatz, 2000). It is possible that there is
a maximum allowed distance between enhancers and
promoters beyond which they cannot effectively “com-
municate,” but that within these boundaries a fair degree
of flexibility is allowed (which might account for the
different experimental results).
Taken together, these data indicate that the transcrip-
tional promoter determines the precise region that will
mutate, in a locus that has been “licensed” for mutation
by the enhancer. One influential model to emerge from
these observations, put forward by Peters and Storb
(1996; Storb et al., 1998b), proposes that a “mutator-
some” is recruited to the vicinity of the variable region
by the Ig enhancer (Figure 2). The complex, which is
proposed to contain a nuclease, is then loaded onto
the DNA through an interaction with the transcription
machinery. It is postulated that this interaction can only
happen between the enhancer and the preinitiation com-
Figure 2. A Model for Somatic Hypermutationplex, such that when the nuclease is deposited in the
(A) Proteins (gray oval) bound to the Ig enhancer recruit a nucleasevicinity of and cleaves the DNA, it cannot reestablish
(red) to the locus.contact with the transcription machinery (which would
(B) Enhancer-promoter interactions deposit the nuclease in the vi-
explain the decay in the rates of hypermutation as a cinity of the transcription initiation complex (hatched oval).
function of the distance from the promoter; Rada and (C) Transcription (green arrow) of the Ig locus is critical for the
initiation of the reaction.Milstein, 2001).
(D) The nuclease travels along the gene with the transcription
complex.The Recognition and Cleavage Phase of SHM
(E) The initiating event is the introduction of an asymmetric DSB
Soon after researchers were able to construct trans- into one of the two sister chromatids.
genes that would hypermutate in vivo, a vast database of (F) 5 end resection exposes a single stranded 3 extension that
invades the intact sister chromatid.mutations began accumulating. Mathematical biologists
(G) New DNA synthesis involves an error-prone polymerase andmining this database have derived models that predict
results in the introduction of point mutations (yellow x) in the sistermany of the features of the process. Rogozin and Kol-
chromatid that sustained the DSB. This model is a synthesis ofchanov (1992) were the first to recognize that preferred
models proposed previously (Brenner and Milstein, 1966; Papavasi-
hypermutation hotspots conformed to a certain nucleo- liou and Schatz, 2000; Peters and Storb, 1996; Maizels, 1995).
tide motif (RGYW or its complement, WRCY). More re-
cently, Shapiro and Wysocki have ranked triplets from
“hottest” to “coldest,” according to a mutability index that a loose sequence specificity is only partially de-
scriptive of the mutator.inferred from a database of unselected mutations (Sha-
piro et al., 1999). The preference of the mutational ma- Because mutations do not seem absolutely sequence
dependent, the possibility remained that perhaps thechinery for certain nucleotides is evolutionarily con-
served (Diaz and Flajnik, 1998), and thus it is likely that mutator was recognizing a structural motif. Gearhart
was the first to postulate a role for DNA secondary struc-it reveals an inherent feature of the reaction. Yet not all
potential hotspots end up being mutated, suggesting ture as a recognition motif (Golding et al., 1987), but
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experimental data did not seem to support that theory able by LM-PCR as a blunt end at levels one to two
(mutations did not necessarily coincide with particular orders of magnitude higher than the downstream end
secondary structure elements (for review, see Winter (Bross et al., 2000; Papavasiliou and Schatz, 2000). Pos-
and Gearhart, 1998). A role for RNA secondary structure sible explanations are that the downstream end contains
was suggested recently by Storb and colleagues. Using a modification that renders it inaccessible to LM-PCR
an artificial transgene containing alternating restriction or the upstream end is “protected” and remains blunt
enzyme sites, they observed that the area of the trans- while the downstream end is further processed in antici-
gene containing the repetitive sequence elements was pation of repair.
more hypermutable than the rest of the transgene (Klotz These data indicate that SHM results in the creation
et al., 1998). This led to the proposal that as the V region of DNA DSBs, although it remains to be proven that such
sequence is transcribed, the nascent mRNA folds into DSBs are intermediates in the hypermutation process. If
transient stem-loop structures that can cause pausing they are intermediates, the DSBs may not be the first,
of the transcriptional machinery and render deposition discrete step of the cleavage reaction. For instance, an
of the mutator kinetically favorable (Storb et al., 1998a). SSB created before DNA replication could be converted
While computer predictions of RNA secondary structure into a DSB by the replication machinery in a fashion that
supported this theory (Storb et al., 1998a), a recent study would generate asymmetric ends (Haber, 2001). Indeed,
by the same investigators did not (Michael et al., 2002). Maizels and colleagues have amplified SSBs from hy-
In transgenes containing predicted secondary structure permutating regions that also colocalize with mutational
elements and/or primary sequence hotspot elements, hotspots (Kong and Maizels, 2001). It remains unclear,
the strongest predictor of hypermutability was, in fact, however, whether these experiments detected the
primary sequence; the hottest nucleotide triplets were unique strand end of a SSB or, alternatively, one of the
mutated most frequently, and if true hotspots were lack- two strand ends generated by a DSB. Because of their
ing, the least cold of the coldspots were preferred. Re- abundance, location, and dependence on transcrip-
gions of high predicted secondary structure (either DNA tional control elements, DSBs are likely to be the end
or RNA) were not inherently highly mutable (Michael product of the cleavage step of the reaction and hence
et al., 2002). In addition, there is no clear relationship the substrate upon which DNA repair must act.
between known RNA polymerase II pause sites and mu-
tations in the human c-MYC gene (which can hypermu- The Repair Phase of SHM
tate when translocated into Ig loci) (Bemark and Neu- A plausible scenario is that SHM is initiated by a B
berger, 2000). Overall, it is clear that the hypermutation cell-specific nuclease that inflicts a DNA break near a
machinery has local sequence preferences and that mutational hotspot. The break would then be repaired
these preferences can be influenced by neighboring se- by ubiquitous factors in an error-prone fashion, intro-
quences. But what the mutator might actually recognize ducing a point mutation in the immediate vicinity of the
remains a mystery. break. A statistical analysis done by Oprea and col-
Equally mysterious, until recently, was the type of leagues has shown that the mutational spectrum derived
DNA cut the nuclease would make. The Brenner-Milstein
from SHM is not very different from that of meiotic
model originally predicted a DNA single strand break
(“spontaneous”) mutation during evolution (Oprea et al.,
(SSB) (Brenner and Milstein, 1966), as it is easy to envi-
2001), suggesting that these processes share repair fac-
sion how to introduce a point mutation during repair of
tors. One way that meiotic mutations can arise is as aa nick or a gap. In recent years, however, the possible
result of repair of unintended breaks, and so these au-involvement of DNA double strand breaks has been sug-
thors and others have suggested that SHM can begested by the finding that 5%–10% of the mutations
viewed as an accelerated form of spontaneous mutationassociated with the SHM reaction are, in fact, insertions
(accelerated in part as a consequence of an increasedand deletions (Goossens et al., 1998; Wilson et al., 1998;
rate of break formation).Wu and Kaartinen, 1995). The first strong evidence for
Mutations can arise “actively” from the error-pronethe involvement of DNA strand lesions (double or single
processing of DNA breaks or “passively” from the ab-stranded) in SHM was provided by Sale and Neuberger,
sence of normal repair machineries. Many investigatorswho showed that TdT was capable of inserting nontem-
have tried to find links between SHM and various repairplated nucleotides into Ig V regions in a hypermutating
pathways (reviewed in Wood, 1998), largely without suc-cell line (Sale and Neuberger, 1998). Direct evidence for
cess. Nucleotide and base excision repair factors doabundant DNA DSBs over hypermutating regions was
not appear to have a role in the reaction. Results fromindependently obtained by two groups (Bross et al.,
mice with deficiencies in mismatch repair factors have2000; Papavasiliou and Schatz, 2000) through the use of
been somewhat contradictory and confusing (reviewedsensitive ligation-mediated (LM)-PCR techniques. Such
in Reynaud et al., 1999), perhaps because B cell re-DSBs were found to be restricted to the variable regions
sponses are perturbed in these animals. For example,or to artificial hypermutating regions and to colocalize
the reduced levels of mutation found in some mismatchstrongly with mutations. It is therefore tempting to spec-
repair-deficient mice may be a secondary consequenceulate that mutational hotspots are also DSB hotspots,
of B cells engaging in fewer rounds of mutation. Thealthough proof of this is currently lacking. Furthermore,
one relatively consistent finding is that Msh2-deficientDSBs are promoter dependent (Bross et al., 2000; Papa-
B cells exhibit an altered spectrum of mutations, withvasiliou and Schatz, 2000) and require Ig enhancer ele-
preferential targeting of G and C nucleotides and ofments (Papavasiliou and Schatz, 2000). Surprisingly, the
hotspots (Reynaud et al., 1999). These results led Neu-DSBs result in asymmetric DNA ends: the upstream end
of the break (the end tethered to the promoter) is detect- berger and colleagues to propose a two-stage model
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for SHM: a first phase that is hotspot focused, G/C nucleotides and preferentially at classic SHM hotspots.
biased, and Msh2 independent, and a second phase, The results strongly support the idea that gene conver-
triggered by events at hotspots, that introduces A/T sion and SHM share a common, initiating DNA lesion
biased mutations at non-hotspot regions and requires (presumably a DSB) and suggest that recombinational
Msh2 (Rada et al., 1998). It is reasonable to think of the repair of a DSB gives rise to gene conversion when
first phase as consisting of a DSB at a hotspot, followed templated from pseudogenes on the same chromo-
by repair that leads to a mutation close to the site of some, or SHM when templated off the sister chromatid
the break. How the second phase of the reaction would (Figures 1 and 2). Presumably, error-free homologous
widen the distribution of mutations, and what role Msh2 repair using the sister chromatid occurs at a high rate
plays in this process, is unclear. It is interesting to note in wild-type DT40 cells and is only revealed when the
that SHM in frogs and of some Ig genes in sharks is repair process is “perverted” (and made error prone) by
strongly G/C biased and hence resembles that in mouse disruption of XRCC2 or XRCC3 (Sale et al., 2001).
B cells deficient in Msh2 (Diaz and Flajnik, 1998). Homologous recombination between sister chroma-
Mismatch repair in yeast and higher eukaryotes is tids is usually error free, so for DSB repair to lead to the
thought to involve initial lesion recognition by a hetero- generation of mutations, a highly error-prone polymer-
dimer consisting of Msh2 and either Msh3 or Msh6, ase should be involved in repair synthesis. Recently, a
followed by recruitment of a Mlh1-Pms2 heterodimer number of highly mutagenic polymerases have been
(Kolodner, 1996). Does Msh2 influence SHM by virtue discovered, four of which (pol , 	, 
, and) are plausible
of its role in conventional mismatch repair? The answer candidates for the mutagenic polymerase(s) of SHM
appears to be no, because inactivation of mismatch (Gearhart and Wood, 2001). There are conflicting reports
repair by targeted disruption of Pms2 does not alter the as to which polymerases are upregulated in germinal
distribution of mutations in SHM (Ehrenstein et al., 2001; centers or in mutating B cell lines, and it has been diffi-
Frey et al., 1998). This finding, while somewhat contro- cult to implicate any of the polymerases definitively in
versial, suggests alternative roles for Msh2 (probably the reaction because of potential functional redundancy
together with Msh6, not Msh3; Wiesendanger et al., and because some result in embryonic lethality when
2000) in SHM. In yeast, Msh2 is involved in the recogni- mutated in mice (e.g., pol ). To date, the evidence is
tion of a variety of DNA structures during DNA DSB strongest for pol  and pol 	 (Gearhart and Wood, 2001).
repair (Paques and Haber, 1997; Sugawara et al., 1997), Because of the significant functional redundancy be-
and it seems to serve as a recruiter of nucleases and tween the polymerases in vitro, it is entirely possible
an initiator of DNA repair. It is therefore conceivable that that they are similarly redundant in vivo.
Msh2 and perhaps other mismatch repair factors have
a role outside the normal mismatch repair pathway, per- Trans-Acting Factors: AID
haps in DNA DSB processing. Our understanding of the molecular mechanism of SHM
In vertebrates, the two main pathways of DSB repair has been severely limited by the paucity of factors thus
are homologous recombination and nonhomologous far shown to be involved in the reaction. Thus, the recent
end joining (NHEJ). These appear to operate predomi-
identification of the activation-induced cytidine deami-
nantly in distinct phases of the cell cycle: G1/early S
nase (AID) has generated much excitement. AID was
for NHEJ and late S/G2 for homologous recombination
isolated in a screen for molecules differentially ex-
(Hendrickson, 1997). The DSBs associated with V(D)J
pressed after induction of CSR in the CH12F3-2 B cellrecombination are repaired by NHEJ and are found al-
lymphoma (Muramatsu et al., 1999). AID has highestmost exclusively in G1 phase cells (Lin and Desiderio,
sequence homology to RNA editing deaminases and1995). Mutation-associated breaks have been postu-
can perform C-to-U deamination in vitro (Muramatsu etlated to be repaired by homologous recombination
al., 1999). AID is preferentially expressed in secondary(Maizels, 1995; Selsing et al., 1996), and indeed SHM
lymphoid organs and, most interestingly, mice and hu-DSBs are found almost exclusively in G2 phase cells
mans deficient in AID have no CSR and severely reduced(Papavasiliou and Schatz, 2000). It appears unlikely that
(if not totally ablated) SHM (Muramatsu et al., 2000; RevyNHEJ resolves any significant fraction of SHM-associ-
et al., 2000), even though germinal centers in AID/ated DSBs: in mice deficient for the NHEJ factor
mice are large, and the initial (targeting) stages of theDNAPKcs, the rate of SHM is unperturbed and so is
CSR reaction seem normal. AID deficiency has no otherthe rate of insertions and deletions associated with the
known consequences, and hence AID appears to beprocess (Bemark et al., 2000). Further striking evidence
involved specifically in CSR and SHM. Strikingly, AID islinking SHM and homologous repair has come recently
also essential for the diversification of chicken Ig Vfrom Neuberger and colleagues, who disrupted either
genes (in the DT40 cell line) by gene conversion (Ara-the XRCC2 or XRCC3 gene (Rad51 paralogs involved
kawa et al., 2002; Harris et al., 2002), which, as discussedin homologous repair) in chicken DT40 cells. Wild-type
above, appears to have strong mechanistic parallelsDT40 cells diversify their Ig variable regions by gene
with SHM (Maizels, 1995; Sale et al., 2001). Thus, inconversion, with few associated untemplated muta-
addition to the obvious functional significance of AID,tions. By contrast, XRCC2- or XRCC3-DT40 cells ex-
its discovery has suddenly linked together these threehibit a dramatic increase in the frequency of untem-
distinct processes.plated point mutations, to levels 10-fold above the gene
The role of AID in these reactions is far from clear,conversion frequency in the wild-type cells (Sale et al.,
and its effect might not even be direct, as AID is thought2001). Interestingly, the frequency of gene conversion
to be an RNA-editing enzyme (Honjo et al., 2002). Itevents is only modestly reduced in the mutant cells.
The point mutations occur almost exclusively at G/C has been postulated that AID edits the mRNA of the
Cell
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Figure 3. Similarities between Hypermutation/Gene Conversion and Class Switch Recombination
AID could function in the first step of all three reactions, initiating break formation. Alternatively, AID could be involved in later stages, either
facilitating the synapsis of the substrates prior to repair or modifying the repair process itself. For SHM and gene conversion, the repair
process is thought to involve homologous recombination (red arrows). For CSR, both nonhomologous end joining and single strand annealing
repair pathways may be involved (red and blue arrows), and mutations are often found near the junctions (yellow x’s). See text for details.
Symbols and abbreviations as in Figure 1.
endonuclease responsible for the DNA lesions in both survival defects) have a severe defect in CSR to all iso-
types except IgG1 (Manis et al., 2002a). The S/S1CSR and SHM (Honjo et al., 2002), and presumably in
gene conversion as well. Given that CSR and SHM have switch junctions from DNAPKcs-deficient B cells closely
resemble those from wild-type B cells, and it remainsbeen proposed to repair breaks by distinct mechanisms
(NHEJ and homologous recombination, respectively), it unclear why CSR to S1 is uniquely DNAPKcs indepen-
dent. Hence, while NHEJ is strongly implicated in CSR,is an attractive idea that the shared factor, AID, would
be involved in the shared, upstream event (the creation it remains uncertain whether it is the only repair process
involved in the reaction. It is also curious that CSR junc-of a DNA lesion; Figure 3).
The inference that CSR ends are repaired by NHEJ tions do not look like typical products of repair by NHEJ,
in that a high frequency of point mutations is found inwas initially supported by data demonstrating that (1)
mice deficient in Ku70 or Ku80 are severely impaired the region surrounding the repaired joint (Dunnick et al.,
1989). This, together with other findings discussed infor CSR both in vivo and in vitro (Casellas et al., 1998;
Manis et al., 1998) and (2) pro-B cells from scid mice the next section, raises the idea that SHM and CSR are
more closely related in their repair phase than previously(deficient in DNAPKcs) cannot switch to IgE (Rolink et
al., 1996). These results had to be interpreted cautiously, thought, which in turn leads us to consider the possibility
that AID edits the mRNA of a factor or factors responsi-however, because Ku-deficient cells have proliferative
and survival defects that could interfere with CSR indi- ble for orchestrating DSB repair (Figure 3).
In an attempt to distinguish whether AID plays itsrectly, and the scid cells were only examined for switch-
ing to IgE. Very recently, these findings were extended essential role in CSR in the generation of DNA lesions
or in coordinating their repair, Nussenzweig and col-by the surprising observation that DNAPKcs-deficient
B cells (which do not have significant proliferative or leagues have looked at the association of repair factors
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with switch region DNA in wild-type and AID/ B cells gous/homeologous repair donor), only one of them is
altered by the reaction (Figure 3). CSR is confined to(Petersen et al., 2001). The repair factors Nbs1 and
the vicinity of switch regions while SHM focuses on thephosphorylated histone H2AX (known as -H2AX) form
rearranged variable region. But as noted above, switchdistinct nuclear foci, easily visualized by immunofluores-
junctions are often mutated. Targeting of the two reac-cence, in areas harboring DNA DSBs. These investiga-
tions to their different substrates is a particular chal-tors found that such foci are detectable over switch
lenge in the Ig heavy chain locus, where the variableregions in wild-type, but not AID-deficient, B cells stimu-
region and S switch sequence are only a few kilobaseslated to undergo CSR. This is consistent with a lack of
apart and are components of the same primary tran-CSR-related DSBs in the absence of AID and supports
script, and hence both regions should be “accessible”the conclusion that AID acts upstream of repair, most
to both reactions. Part of the explanation for target spec-likely functioning in initiating DSB formation.
ificity may lie in differences in the enhancer elementsA similar attempt at deciphering the role of AID, this
that appear to be required for the two processes. Fortime in SHM, reached a seemingly opposite conclusion.
instance, the  intronic enhancer is required for SHMWe have examined DNA DSB formation in germinal cen-
whereas the 3 IgH enhancer is important for CSR (Pi-ter B cells from wild-type and AID-deficient mice and
naud et al., 2001).found that DSBs are detectable at equal frequencies in
Both SHM and CSR are tightly linked to transcription,the two. Furthermore, in Ramos B cells overexpressing
but the role played by transcription remains a mystery.a dominant-negative form of AID, SHM is blocked but
Movement of the transcriptional apparatus along theDSBs are, if anything, increased in abundance com-
gene is postulated to be necessary for SHM (Peters andpared to control cells (Papavasiliou and Schatz, 2002).
Storb, 1996) (Figure 2), whereas for CSR it has beenEven if DSBs are not direct intermediates in the SHM
suggested that a transient RNA:DNA duplex (formedreaction, but are instead byproducts of the initiating
between the nascent transcript and the template strandlesion (e.g., a SSB), this result still indicates that the
of the switch region DNA) might be the secondary struc-initiating lesion is present in AID-deficient B cells. We
ture recognized by the CSR nuclease(s) (Manis et al.,conclude that AID is not required for strand lesions in
2002b; Tian and Alt, 2000). SHM and CSR are thoughtSHM and likely acts by editing the RNA of either a repair
to involve the generation of one or two DNA DSBs, re-factor or a factor that recruits the repair machinery.
spectively, but whether the initiating lesion is a DSB orTaken together, these results indicate either (1) that
a single strand nick that is converted into a DSB (throughAID plays different roles in CSR and SHM (presumably
S phase-dependent DNA replication) is unknown.by editing different RNA species) or (2) that in CSR, as
Surprisingly, Msh2 deficiency creates a similar pheno-in SHM, AID acts in the repair phase of the reaction,
type in SHM and CSR: a focusing on intrinsic hotspotsperhaps to modify repair factor(s) and enable formation
in SHM, and a focusing of junctions on consensus switchof the Nbs1/-H2AX foci. Clearly, our understanding of
motifs in CSR (Ehrenstein and Neuberger, 1999). Thethe mechanisms of SHM and CSR remains rudimentary,
role of Msh2 in these reactions appears to be distinctbut significant advances may come quickly through a
from that of standard mismatch repair, because CSRbetter characterization of the relevant DNA lesions (in-
junctions from Pms2-deficient mice do not show a simi-cluding identification of the nuclease(s) involved) and of
lar focusing on consensus motifs and exhibit unusuallycourse the discovery of the putative target RNA(s) edited
long regions of microhomology (Ehrenstein et al., 2001;by AID. Progress on these issues may come quickly,
Schrader et al., 2002). Notably, the GAGCT switch con-given recent findings that expression of AID is sufficient
sensus sequence matches the RGYW hotspot for SHM.to activate SHM in B cell hybridomas (Martin et al., 2002)
Finally, the repair of CSR DSBs is proposed to takeand CSR in 3T3 fibroblasts (Okazaki et al., 2002).
place in the G1 phase of the cell cycle, as CSR repair
foci are more frequent in G1 (Petersen et al., 2001). CSR
CSR and SHM: How Deep Are the Parallels? breaks are thought to be repaired by NHEJ, but CSR-
The discovery that CSR and SHM (and Ig gene conver- associated repair foci contain Nbs1 and Rad50 (Pe-
sion, which for simplicity we will consider a variant of tersen et al., 2001), and these proteins along with Mre11
SHM) depend on AID is the latest item on a growing list participate in the human single strand annealing (SSA)
of similarities between the two reactions (reviewed in pathway (Karran, 2000) (a role for Mre11/Rad50/Nbs1
Manis et al., 2002b). How deep do the mechanistic paral- in NHEJ in higher eukaryotes remains uncertain [Huang
lels run, and might CSR and SHM be different repair and Dynan, 2002]). The involvement of a variant of SSA
outcomes of similar DNA cleavage reactions (Figure 3)? in CSR would not be inconsistent with the data at hand
Both reactions take place in germinal center B cells in (Figure 3), as previously hypothesized (the “illegitimate
response to stimulation by antigen but, importantly, they priming model” [Dunnick et al., 1993], reviewed in Stav-
are not obligate partners, since a number of in vivo and nezer [1996]). The longer regions of microhomology
in vitro situations have been identified in which cells seen in some switch junctions from Mlh1- and Pms2-
perform one reaction or the other, but not both (Honjo deficient B cells (Ehrenstein et al., 2001; Schrader et al.,
et al., 2002). The substrates for the two reactions have 2002) may reflect the participation of SSA.
obvious differences, but also some intriguing overlap. In contrast, emerging data suggest that SHM DSBs
CSR is inherently a two substrate process, requiring are repaired in G2, and thus homologous recombination
the synapsis of two nonhomologous switch sequences. is an attractive mechanism for repair of such DSBs into
SHM and gene conversion differ from CSR in that while mutations (Papavasiliou and Schatz, 2000; Sale et al.,
they also may require the interaction of two DNA se- 2001) as well as for the generation of the small amounts
of insertions and deletions associated with the processquences (the V region to be mutated and the homolo-
Cell
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